Prognostic Value of Glioma Cancer Stem Cell Isolation in Survival of Primary Glioblastoma Patients
Table 1
Cohorts of primary glioblastoma patients who were positive or negative for glioma cancer stem cells (gCSCs) [6].
Patients
gCSC candidates
Age (years)
Sex
Podoplanin
CD133
Nestin
gCSC positive
gCSC0315
57
F
−
+
+
gCSC0426
44
F
−
+
+
gCSC0520
72
F
−
+
+
gCSC0713
55
F
−
−
−
gCSC0504
39
M
+
+
+
gCSC1120
48
F
+
+
+
gCSC0503
64
M
+
+
+
gCSC0114
53
M
−
+
+
gCSC0213
51
F
−
+
+
gCSC0228
68
M
+
+
+
gCSC0308
61
M
+
+
+
gCSC0924
11
M
+
+
+
gCSC0510
49
F
+
+
+
gCSC0627
61
M
+
+
+
gCSC0520
34
M
+
+
+
gCSC negative
gCSC0406
38
F
gCSC08241
71
F
gCSC1005
59
F
gCSC1124
63
F
gCSC0226
28
M
gCSC0309
59
M
gCSC0803
60
F
gCSC08242
65
F
gCSC0620
66
F
gCSC0928
46
M
gCSC1108
82
M
gCSC0219
60
M
gCSC0528
66
F
gCSC0610
49
M
gCSC0702
63
M
gCSC0709
24
M
gCSC0816
57
M
gCSC0822
62
F
gCSC1118
57
F
gCSC1218
44
M
gCSC0102
68
M
gCSC0106
57
F
gCSC0529
60
F
gCSC1102
57
M
gCSC: glioma cancer stem cell; M: male; F: female; +: positive for expression as assessed using immunocytochemical methods [6]; −: negative for expression, as assessed using immunocytochemical methods [6].
